Immediately Sequential Bilateral Cataract Surgery (ISBCS)

Immediately Sequential Bilateral Cataract Surgery (ISBCS)

Global History and Methodology

Qi, Susan Ruyu; Chen, Mike Yuan; Johansson, Bjorn; Hebert, Melanie; Arshinoff, Steve A.; Perez-Silguero, David; Claoue, Charles

Elsevier Science & Technology

11/2022

418

Mole

Inglês

9780323953092

15 a 20 dias

Descrição não disponível.
1. The History of Cataract Surgery from ancient times to ISBCS 2. Why did we not always do ISBCS? (What had to be overcome?) 3. The logic behind bilateral cataract surgery 4. The argument for and against ISBCS 5. ISBCS in children 6. The carbon footprints of ISBCS and DSBCS 7. The risk of bilateral endophthalmitis and IC antibiotics 8. Ophthalmic Viscosurgical Devices for ISBCS 9. Biometry for ISBCS 10. IOL Power Selection in 2022 - Best Practices for ISBCS and DSBCS 11. ISBCS and presbyopia correcting IOLs 12. Inclusions and Exclusions for ISBCS 13. Ethics surrounding ISBCS 14. Medico-legal Aspects of ISBCS 15. ISBCS and money 16. The Evolution of Bilateral Cataract Surgery - Global perspective 17. "Nothing is more powerful than an idea whose time has come." Why was ISBCS resisted and how was this overcome? 18. The International Society of Bilateral Cataract Surgeons 19. Anesthesia for ISBCS 20. ISBCS - the patient's perspective 21. Is ISBCS appropriate for MSICS? 22. FLACS and ISBCS 23. The COVID-19 pandemic and the uptake of ISBCS 24. ISBCS: What we have learned, and how has it advanced ophthalmology? 25. The future and limitations of ISBCS
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Ampicillin; Barriers; Best practices; Bilateral cataract surgery; Bilateral complications; Bilateral congenital cataract; Bilateral pediatric cataract; Bilateral pediatric cataract extraction; Bilateral pediatric cataract surgery; Bilateral pediatric lensectomy; Bilateral simultaneous cataract surgery; Bilateral simultaneous postoperative endophthalmitis; Biometric formulas; Biometry; Carbon footprint; Cataract surgery carbon footprint; Cefuroxime; Co-morbidity; Contra-indications; Cost; Cost effectiveness; Delayed sequential bilateral cataract surgery; Diffractive IOL; DSBCS; Economy; EDOF; Efficiency; Endophthalmitis and pediatric cataract surgery; Ethics of cataract surgery; Exclusions; Extended depth of focus; Greenhouse gasses; Immediately sequential bilateral cataract surgery; Indications; Intracameral antibiotics; Intracameral prophylactic antibiotics; Intraocular infection; Intraocular lens choice; Intraocular lens formulas; IOL power Selection; IOLMaster; ISBCS; Jack-in-the-box